Neuro Diagnostic Devices

Third Eye Diagnostics is developing the Cerepress, a first-of-its-kind non-invasive intracranial pressure monitor that gathers information from the patient's eye. The technology is based on one issued patent, one pending patent, and two applications in progress on methods and apparatus that correlate ICP with measurements taken from the blood vessels within the eye. The Cerepress measures blood pressure in the eye's central retinal vein (CRV) which highly correlates to intracranial pressure.

Pelikan Technologies is dedicated to the development of hand-held diagnostic and monitoring devices capable of improving the screening and management of a variety of medical conditions. In addition to diabetes, the company's versatile technology platform has applications across a range of other medical conditions that involve blood screening and monitoring. Point-of-care testing and diagnostic panel test systems also represent markets that can benefit from Pelikan's technology. The Pelikan Sun can improve the quality of life for people with diabetes by combining several of the company's technologies into the most convenient and effective blood glucose self-monitoring device available. Pelikan's line of diabetes management tools will address the pain and inconvenience that has stymied the industry's manufacturers, and plagued people with diabetes, contributing to poor blood glucose monitoring compliance. By targeting these barr

Everest currently markets a newborn hearing screening device that combines evoked otoacoustic emissions and auditory brainstem response. The company is based in St. Louis, MO, and has under development a hand-held, battery-operated monitoring device enabling the anesthetician to know what is happening in the entire brain while the patient is under anesthesia.

MEC Dynamics is a medical devices company developing and manufacturing point-of-care diagnostic products, using its proprietary technology. The company's devices have been designed for use in the both physician's office as well as the patient's home. They enable the 'real time' measurement of key blood analytes for early detection and more effective management of a variety of diseases including diabetes, cardiovascular diseases and cancer. Chronic and life-threatening diseases occurring in both industrial and developing countries could be better treated through early detection and proper monitoring. MEC aims to be a global developer and manufacturer of point-of-care diagnostic products using its technology platform. MEC's lead product, AvieA1c, is FDA 510K approved and NGSP certified.

Innara Health is developing new feeding technologies to measure and treat infants, children, and adults that struggle with suck, swallow, and breathe coordination. The company's flagship product is the FDA-approved NTrainer System, a neonatal technology that assesses and develops non-nutritive suck skills for newborns and infants born prematurely. Innara aims to help improve infants' time to oral feed and, in turn, decrease the length of their hospital stay. The company was founded in 2006 and is based in Olathe, Kansas.

BrainScope develops technology that aims to enable physicians to evaluate neurological function in trauma cases as well as to diagnose medical conditions that impact brain status.